These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37561771)

  • 1. Assessment of the relationship between the level of patient knowledge on warfarin therapy and the quality of oral anticoagulation: A systematic review and meta-analysis.
    Praxedes MFDS; Silva JLPD; Cruz AJAD; Viana CC; Barbosa HC; Guimarães NS; Martins MAP
    PLoS One; 2023; 18(8):e0289836. PubMed ID: 37561771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
    Baker JW; Pierce KL; Ryals CA
    J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review.
    Tadesse TA; Tegegne GT; Yadeta D; Chelkaba L; Fenta TG
    Thromb J; 2022 Oct; 20(1):58. PubMed ID: 36192776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin.
    Feldeisen D; Alexandris-Souphis C; Haymart B; Gu X; Perry L; Watts S; Kozlowski R; Kozlowski J; Froehlich JB; Barnes GD; Kline-Rogers E
    J Thromb Thrombolysis; 2023 Jan; 55(1):141-148. PubMed ID: 36326967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
    Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
    Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-influence on the time in therapeutic range (TTR) during oral anticoagulation with coumarin derivatives: Systematic review and meta-analysis.
    Costa Viana C; da Silva Praxedes MF; Freitas Nunes de Sousa WJ; Bartolazzi F; Sousa Vianna M; Padilha da Silva JL; Parreiras Martins MA
    Br J Clin Pharmacol; 2021 Dec; 87(12):4488-4503. PubMed ID: 33973668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis.
    Vestergaard AS; Skjøth F; Larsen TB; Ehlers LH
    PLoS One; 2017; 12(11):e0188482. PubMed ID: 29155884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(12):1-114. PubMed ID: 23074516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.
    Clarkesmith DE; Pattison HM; Khaing PH; Lane DA
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008600. PubMed ID: 28378924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' and clinicians' perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis.
    Osasu YM; Cooper R; Mitchell C
    BMC Fam Pract; 2021 Dec; 22(1):254. PubMed ID: 34937557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-report instruments for assessing adherence to warfarin therapy: a systematic review.
    Vianna MS; da Silva Praxedes MF; de Araújo VE; Ferreira CB; de Sousa WJFN; Viana CC; Martins MAP
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1765-1781. PubMed ID: 34292359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Patients' Knowledge and Adherence to Anticoagulants, and Its Effect on Coagulation Control.
    Ahmed H; Saddouh EA; Abugrin ME; Ali AMM; Elgdhafi EO; Khaled A; Tarek A; Elhadi M
    Pharmacology; 2021; 106(5-6):265-274. PubMed ID: 33202413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol of a clinical trial study involving educational intervention in patients treated with warfarin.
    Costa JMD; Marcolino MS; Torres HC; Resende RE; Souza RP; Barbosa HC; Ribeiro DD; Martins MAP
    Medicine (Baltimore); 2019 May; 98(22):e15829. PubMed ID: 31145324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the effectiveness of pharmacist-managed warfarin anticoagulation with other models: a systematic review and meta-analysis.
    Zhou S; Sheng XY; Xiang Q; Wang ZN; Zhou Y; Cui YM
    J Clin Pharm Ther; 2016 Dec; 41(6):602-611. PubMed ID: 27677651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin control in Hong Kong clinical practice: a single-centre observational study.
    Lam ASM; Lee IMH; Mak SKS; Yan BPY; Lee VWY
    Hong Kong Med J; 2020 Aug; 26(4):294-303. PubMed ID: 32729553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of psychometric properties of the Brazilian version of the oral anticoagulation knowledge test.
    Praxedes MF; de Abreu MH; Paiva SM; Mambrini JV; Marcolino MS; Martins MA
    Health Qual Life Outcomes; 2016 Jun; 14():96. PubMed ID: 27342960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study.
    Li Y; Yu J; Kuang Y; Wu C; Yang L; Fang Q; Pei Q; Yang G
    Curr Med Res Opin; 2020 Sep; 36(9):1433-1439. PubMed ID: 32677855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
    Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
    Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
    Baker WL; Cios DA; Sander SD; Coleman CI
    J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.